A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases

Journal of Neuro-Oncology

Volumn 87, Issue 1, 2008, Pages 85-90

  Iwamoto, Fabio M ^a   Omuro, Antonio M ^a,b   Raizer, Jeffrey J ^a,c   Nolan, Craig P ^a   Hormigo, Adí Lia ^a   Lassman, Andrew B ^a   Gavrilovic, Igor T ^a   Abrey, Lauren E ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Brain metastasis; Breast cancer; Lung cancer; Temozolomide; Vinorelbine

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID; DACARBAZINE; NAVELBINE; TEMOZOLOMIDE;

ADULT; AGED; ANEMIA; ARTICLE; BLADDER CANCER; BONE MARROW SUPPRESSION; BRAIN METASTASIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; COMBINATION CHEMOTHERAPY; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ENDOMETRIUM CANCER; FEMALE; HEAD AND NECK CANCER; HUMAN; KARNOFSKY PERFORMANCE STATUS; KIDNEY CANCER; LEUKOPENIA; LUNG CANCER; LYMPHOCYTOPENIA; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PROGNOSIS; RECURRENT DISEASE; SIDE EFFECT; STEREOTAXIC SURGERY; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING; WHOLE BODY CT;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; DACARBAZINE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SURVIVAL ANALYSIS; VINBLASTINE;

EID: 38649139119     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-007-9491-3     Document Type: Article

References (20)

1. Omuro AM, Abrey LE (2004) Brain metastases. Curr Neurol Neurosci Rep 4:205-210
2. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ et al (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494-500
3. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665-1672
4. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996
5. Yung WK, Prados MD, Yaya-Tur R, Rosenfeld SS, Brada M, Friedman HS et al (1999) Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol 17:2762-2771
6. Agarwala SS, Kirkwood JM, Gore M, Dreno B, Thatcher N, Czarnetski B et al (2004) Temozolomide for the treatment of brain metastases associated with metastatic melanoma: A phase II study. J Clin Oncol 22:2101-2107
7. Raymond E, Izbicka E, Soda H, Gerson SL, Dugan M, Von Hoff DD (1997) Activity of temozolomide against human tumor colony-forming units. Clin Cancer Res 3:1769-1774
8. Abrey LE, Olson JD, Raizer JJ, Mack M, Rodavitch A, Boutros DY et al (2001) A phase II trial of temozolomide for patients with recurrent or progressive brain metastases. J Neurooncol 53:259-265
9. Christodoulou C, Bafaloukos D, Kosmidis P, Samantas E, Bamias A, Papakostas P et al (2001) Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases. Ann Oncol 12:249-254
10. Fornier M, Norton L (2005) Dose-dense adjuvant chemotherapy for primary breast cancer. Breast Cancer Res 7:64-69
11. Wick W, Steinbach JP, Kuker WM, Dichgans J, Bamberg M, Weller M (2004) One week on/one week off: A novel active regimen of temozolomide for recurrent glioblastoma. Neurology 62:2113-2115
12. Gregory RK, Smith IE (2000) Vinorelbine-a clinical review. Br J Cancer 82:1907-1913
13. Omuro AM, Raizer JJ, Demopoulos A, Malkin MG, Abrey LE (2006) Vinorelbine combined with a protracted course of temozolomide for recurrent brain metastases: A phase I trial. J Neurooncol 78:277-280
14. Dziadziuszko R, Ardizzoni A, Postmus PE, Smit EF, Price A, Debruyne C et al (2003) Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965). Eur J Cancer 39:1271-1276
15. Giorgio CG, Giuffrida D, Pappalardo A, Russo A, Santini D, Salice P et al (2005) Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: Phase II study. Lung Cancer 50:247-254
16. Christodoulou C, Bafaloukos D, Linardou H, Aravantinos G, Bamias A, Carina M et al (2005) Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: A Hellenic Cooperative Oncology Group (HeCOG) phase II study. J Neurooncol 71:61-65
17. Caraglia M, Addeo R, Costanzo R, Montella L, Faiola V, Marra M et al (2006) Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours. Cancer Chemother Pharmacol 57:34-39
18. Robinet G, Thomas P, Breton JL, Lena H, Gouva S, Dabouis G et al (2001) Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Francais de Pneumo-Cancerologie (GFPC) protocol 95-1. Ann Oncol 12:59-67
19. Bernardo G, Cuzzoni Q, Strada MR, Bernardo A, Brunetti G, Jedrychowska I et al (2002) First-line chemotherapy with vinorelbine, gemcitabine, and carboplatin in the treatment of brain metastases from non-small-cell lung cancer: A phase II study. Cancer Invest 20:293-302
20. Tolcher AW, Gerson SL, Denis L, Geyer C, Hammond LA, Patnaik A et al (2003) Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules. Br J Cancer 88:1004-1011